Discovery and Validation of Methylated DNA Markers From Pancreatic Neuroendocrine Tumors

Discovery and Validation of Methylated DNA Markers From Pancreatic Neuroendocrine Tumors

Background and Aims: Methylated DNA markers (MDMs) accurately identify several different cancer types, but there are limited data for pancreatic neuroendocrine tumors (pNETs). We aimed to identify MDM candidates in tissue that differentiate pNETs from normal pancreas. Methods: wUsing DNA from frozen...

Full description

Bibliographic Details
Main Authors: Shounak Majumder, Thorvardur R. Halfdanarson, Calise K. Berger, Patrick H. Foote, Xiaoming Cao, Maria C. McGlinch, Brianna J. Gysbers, Jaime de La Fuente, Mariah J. Robran, Karen A. Doering, Kelli N. Burger, William E. Bamlet, Ann L. Oberg, Douglas W. Mahoney, Rondell P. Graham, William R. Taylor, Gloria M. Petersen, John B. Kisiel
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Gastro Hep Advances
Subjects:
Neuroendocrine Tumors
DNA Methylation
Biomarker
Pancreatic Neoplasms
Online Access:http://www.sciencedirect.com/science/article/pii/S2772572322000139

Internet

http://www.sciencedirect.com/science/article/pii/S2772572322000139

Similar Items